PubMed Health⌕ Search

PubMed · 3944292

Improved precision in calculated T1 MR images using multiple spin-echo acquisition.

Abstract

Calculated T1 images require that magnetic resonance signals be detected at several inversion or repetition times (TR). Multiple spin-echo (SE) acquisitions provide several measurements of the magnetization at each TR, the signal size diminishing according to T2 decay. In this work we review one method (Case 1) for estimating T1 from single echoes and present four new methods (Cases 2-5) in which multiple acquired echoes are used. For Case 2 a fit is performed using the first echo at each TR, repeated using second echoes, etc., and the final T1 estimate is the simple average of the individual fits at each echo time (TE). For Case 3 the optimum weighted average is performed. For Cases 4 and 5 synthetic SE images are generated at each TR prior to the T1 fit, Case 4 using a synthetic TE of zero, and Case 5 using a TE providing maximum signal-to-noise ratio in the synthetic image. The relative precision in T1 provided by each method is calculated rigorously. It is proven that Cases 3 and 5 are optimum and equivalent and can theoretically reduce the noise in T1 images by as much as 40% over Case 1 with no increase in scanning time. Approximations are proposed that enable the optimum methods to be implemented in a practical fashion. Experimental images are presented that verify the relative predicted behavior.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J Riederer, S A Bobman, J N Lee, F Farzaneh, H Z Wang. Improved precision in calculated T1 MR images using multiple spin-echo acquisition.. https://doi.org/10.1097/00004728-198601000-00022

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗